WeVote
Log In

Bill

Bill

HB 761

HEALTH/CANCER: Provides with respect to the advisory board created to recommend new treatments for rare cancers (EN NO IMPACT See Note)

2026 Regular Session Introduced by Roy Adams and 17 co-sponsors

Louisiana establishes advisory board to recommend rare cancer treatments; unclear scope and "no impact" designation suggest limited substantive effect.

Effective date: 06/08/2026.
0
WeVote Research Nonpartisan
Bill Summary · HB 761

Legislative bill overview

HB 761 establishes or modifies an advisory board tasked with recommending new treatments for rare cancers in Louisiana. The bill has been flagged with "OR NO IMPACT," suggesting it may be largely procedural, clarifying existing authority, or addressing a technical matter rather than creating substantive new programs or funding.

Why is this important

Rare cancers affect a small percentage of the population but often lack treatment options due to limited research incentives and patient populations. An advisory board focused on identifying and recommending emerging treatments could help ensure Louisiana patients have access to cutting-edge therapies and improve coordination between oncologists, researchers, and policymakers on rare cancer care.

Potential points of contention

  • Lack of specificity: The bill summary provides minimal detail about the board's composition, authority, budget, or decision-making process, making it difficult to assess its actual scope
  • "No impact" designation: The "OR NO IMPACT" notation suggests the bill may be procedurally hollow or redundant with existing structures, raising questions about its practical value
  • Resource allocation: Without clarity on whether the board will have dedicated funding or staff, it may function as advisory only with limited ability to influence treatment access or research priorities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.